In complicated UTIs, cefepime-taniborbactam increased treatment success vs. meropenem at 19 to 23 d.
Where this comes from
- Record sourced from PubMed, PMID 38830218.
- Also identified by DOI 10.7326/ANNALS-24-00447-JC.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Wagenlehner FM, Gasink LB, McGovern PC, et al; CERTAIN-1 Study Team. <b>Cefepime-taniborbactam in complicated urinary tract infection.</b> N Engl J Med. 2024;390:611-622. 38354140.
Medical subject headings
- Anti-Bacterial Agents
- Cefepime
- Meropenem
- Urinary Tract Infections